[LGND] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 262.53%
YoY- -23.14%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 50,464 33,375 27,995 29,267 38,185 21,619 19,521 88.03%
PBT 30,665 12,071 8,300 6,193 7,230 804 -9,644 -
Tax 37,675 3,645 2,242 1,114 10,355 160 -3,881 -
NP -7,010 8,426 6,058 5,079 -3,125 644 -5,763 13.90%
Tax Rate -122.86% -30.20% -27.01% -17.99% -143.22% -19.90% - -
Total Cost 57,474 24,949 21,937 24,188 41,310 20,975 25,284 72.62%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -13.89 25.25 21.64 17.35 -8.18 2.98 -29.52 -39.42%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.34 0.40 0.29 0.24 -0.15 0.03 -0.28 13.77%
EPS Diluted -0.33 0.36 0.26 0.22 -0.15 0.03 -0.28 11.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.